Asset Allocation

As of November 30, 2025.
Type % Net
Cash 1.09%
Stock 33.56%
Bond 61.96%
Convertible 0.00%
Preferred 2.23%
Other 1.16%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.67%    % Emerging Markets: 0.39%    % Unidentified Markets: 0.94%

Americas 92.53%
92.37%
Canada 78.32%
United States 14.04%
0.16%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.88%
United Kingdom 2.83%
2.83%
Denmark 0.00%
France 0.83%
Germany 0.02%
Ireland 0.28%
Italy 0.19%
Netherlands 0.54%
Sweden 0.91%
Switzerland 0.03%
0.20%
Poland 0.20%
0.02%
Israel 0.02%
Greater Asia 0.65%
Japan 0.47%
0.04%
Australia 0.03%
0.14%
Singapore 0.14%
0.00%
Unidentified Region 0.94%

Bond Credit Quality Exposure

AAA 24.70%
AA 16.12%
A 33.26%
BBB 15.50%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.18%
Not Available 9.24%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
17.76%
Materials
0.57%
Consumer Discretionary
4.99%
Financials
9.96%
Real Estate
2.25%
Sensitive
14.94%
Communication Services
1.54%
Energy
0.00%
Industrials
6.93%
Information Technology
6.47%
Defensive
3.65%
Consumer Staples
2.41%
Health Care
0.82%
Utilities
0.42%
Not Classified
63.64%
Non Classified Equity
0.00%
Not Classified - Non Equity
63.64%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 14.26%
Corporate 46.40%
Securitized 1.47%
Municipal 26.30%
Other 11.57%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.17%
Less than 1 Year
0.17%
Intermediate
64.00%
1 to 3 Years
12.83%
3 to 5 Years
14.16%
5 to 10 Years
37.02%
Long Term
32.15%
10 to 20 Years
11.87%
20 to 30 Years
16.48%
Over 30 Years
3.80%
Other
3.68%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial